Unravelling drug-drug interactions in pigs: Induction of hepatic cytochrome P450 1A (CYP1A) metabolism after the in-feed medication with the anthelmintic fenbendazole

被引:0
|
作者
Ichinose, Paula [1 ,2 ]
Miro, Maria Victoria [1 ,2 ]
Larsen, Karen [1 ,2 ]
Lifschitz, Adrian [1 ,2 ]
Virkel, Guillermo [1 ,2 ]
机构
[1] Univ Nacl Ctr Prov Buenos Aires UNCPBA, Fac Ciencias Vet, Tandil, Buenos Aires, Argentina
[2] UNCPBA, Ctr Invest Vet Tandil CIVETAN, CICPBA, CONICET, Tandil, Buenos Aires, Argentina
关键词
Fenbendazole; Cytochrome P450; Enzyme induction; Aflatoxin B1; Liver; Pigs; ALPHA-NAPHTHOFLAVONE; AFLATOXIN B-1; BIOTRANSFORMATION ENZYMES; LIQUID-CHROMATOGRAPHY; LIVER; EXPRESSION; ACTIVATION; SWINE; SULFOXIDATION; FLUBENDAZOLE;
D O I
10.1016/j.rvsc.2023.105113
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
The anthelmintic fenbendazole (FBZ) undergoes hepatic S-oxygenation by monooxygenases belonging to the cytochrome P450 (CYP) and flavin-monooxygenase (FMO) families. The in-feed medication with FBZ induced CYP1A-dependent metabolism in pig liver. This fact may alter the metabolism of the anthelmintic itself, and of CYP1A substrates like aflatoxin B1 (AFB1). This work evaluated the effect of the in-feed administration of FBZ on CYP1A-dependent metabolism, on its own pattern of hepatic S-oxygenation, and on the metabolism of AFB1. Landrace piglets remained untreated (n = 5) or received a pre-mix of FBZ (n = 6) in feed for 9 days. Pigs were slaughtered for preparation of liver microsomes used for: CYP content determination; monitoring the CYP1A-dependent enzyme activities, 7-ethoxyresorufin O-deethylase (EROD) and 7-methoxyresorufin O-demethylase (MROD); measurement of FBZ (50 mu M) S-oxygenation, and AFB1 (16 nM) disappearance from the incubation medium. In microsomes of FBZ-treated animals, EROD and MROD increased 19-fold (p = 0.002) and 14-fold (p = 0.003), respectively. An enhanced (3-fold, p = 0.004) participation of the CYP pathway in FBZ S-oxygenation was observed in the liver of piglets treated with the anthelmintic (210 +/- 69 pmol/min.nmol CYP) compared to untreated animals (68 +/- 34 pmol/min.nmol CYP). AFB1 metabolism was 93% higher (p = 0.009) in the liver of FBZ-treated compared to untreated pigs. Positive and significant (p < 0.05) correlations were observed between CYP1A-dependent enzyme activities and FBZ or AFB1 metabolism. The sustained administration of FBZ caused an auto-induction of the CYP1A-dependent S-oxygenation of this anthelmintic. The CYP1A induction triggered by the anthelmintic could amplify the production of AFB1 metabolites in pig liver, including the hepatotoxic AFB1-derived epoxide.++
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Inhibition of human cytochrome P450 enzymes by 1,4-dihydropyridine calcium antagonists: prediction of in vivo drug-drug interactions
    Katoh, M
    Nakajima, M
    Shimada, N
    Yamazaki, H
    Yokoi, T
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 55 (11-12) : 843 - 852
  • [32] Drug metabolism of ciprofloxacin, ivacaftor, and raloxifene by Pseudomonas aeruginosa cytochrome P450 CYP107S1
    Kandel, Sylvie E.
    Tooker, Brian C.
    Lampe, Jed N.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2024, 300 (08)
  • [33] Identification, functional characterization and expression profiling of cytochrome p450 1A (CYP1A) gene in Labeo rohita against emamectin benzoate
    Dar, Showkat Ahmad
    Chatterjee, Arunava
    Rather, Mohd Ashraf
    Chetia, Diganta
    Srivastava, Prem P.
    Gupta, Subodh
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2020, 158 : 1268 - 1278
  • [34] Cloning of cytochrome P450 1A (CYP1A) genes from the hermaphrodite fish Rivulus marmoratus and the Japanese medaka Oryzias latipes
    Kim, CI
    Kim, YJ
    Yoon, YD
    Kawamura, S
    Lee, YS
    Lee, JS
    MARINE ENVIRONMENTAL RESEARCH, 2004, 58 (2-5) : 125 - 129
  • [35] Pharmacogenetics of Cytochrome P450 (CYP) 1A2 and Variability in Psychotropic Drug Response
    Antonio Carrillo, Juan
    Gervasini, Guillermo
    CURRENT PSYCHIATRY REVIEWS, 2006, 2 (01) : 77 - 94
  • [36] Metabolism of the anthelmintic drug niclosamide by cytochrome P450 enzymes and UDP-glucuronosyltransferases: metabolite elucidation and main contributions from CYP1A2 and UGT1A1
    Lu, Danyi
    Ma, Zhiguo
    Zhang, Tianpeng
    Zhang, Xingwang
    Wu, Baojian
    XENOBIOTICA, 2016, 46 (01) : 1 - 13
  • [37] APPLICATION OF PHYSIOLOGICALLY BASED PHARMACOKINETIC (PBPK) MODELING FOR PREDICTION OF COMPLEX DRUG-DRUG INTERACTIONS (DDIs) INVOLVING OATPIB1-MEDIATED UPTAKE AND CYTOCHROME P450 (CYP) METABOLISM AND MULTIPLE INHIBITORS.
    Yeo, K. Rowland
    Jamei, M.
    Aarabi, M.
    Rostami-Hodjegan, A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S47 - S48
  • [38] Drug mediated induction of cytochrome P450 1A1 in human hepatoma cell lines
    Krusekopf, S
    Kleeberg, U
    Hildebrandt, AG
    Ruckpaul, K
    FASEB JOURNAL, 1997, 11 (09): : A822 - A822
  • [39] Evaluation of iberdomide and cytochrome p450 drug-drug interaction potential in vitro and in a phase 1 study in healthy subjects
    Allison Gaudy
    Christian Atsriku
    Ying Ye
    Kimberly MacGorman
    Liangang Liu
    Yongjun Xue
    Sekhar Surapaneni
    Maria Palmisano
    European Journal of Clinical Pharmacology, 2021, 77 : 223 - 231
  • [40] Evaluation of iberdomide and cytochrome p450 drug-drug interaction potential in vitro and in a phase 1 study in healthy subjects
    Gaudy, Allison
    Atsriku, Christian
    Ye, Ying
    MacGorman, Kimberly
    Liu, Liangang
    Xue, Yongjun
    Surapaneni, Sekhar
    Palmisano, Maria
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 77 (02) : 223 - 231